Company news
Bio-Techne Corp news in 2026
Bio-Techne Corp's news releases, calls and decks from 2026, newest first.
Bio-Techne declares dividend
November 3, 2026
Amendment to Annual Report (Form 10-K/A)
October 28, 2026
Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development
October 8, 2026
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
September 23, 2026
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
September 22, 2026
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
September 1, 2026
Bio-Techne Corrects Dividend Announcement
August 13, 2026
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
August 12, 2026
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
July 8, 2026
Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
June 25, 2026
Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
June 4, 2026
Bio-Techne Releases Third Quarter Fiscal 2026 Results
May 6, 2026
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 4, 2026
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
April 16, 2026
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
April 13, 2026
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET Suite
March 26, 2026
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
March 24, 2026
Evolve Announces March 2026 Distributions for UltraYield ETFs and Certain Evolve Funds
March 18, 2026
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories
February 16, 2026
Bio-Techne Announces Changes to its Leadership Team
February 11, 2026
Bio-Techne Releases Second Quarter Fiscal 2026 Results
February 4, 2026
Bio-Techne Declares Dividend
February 4, 2026
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
February 2, 2026
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
January 28, 2026
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
January 19, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (January 2026)
Investor deck · 14 slides · January 2026